Allopregnanolone

From WikiMD's WELLNESSPEDIA

(Redirected from Brexanolone)

Allopregnanolone[edit]

Allopregnanolone is a neurosteroid that is derived from the hormone progesterone. It is known for its role in modulating the central nervous system and has been implicated in various physiological and pathological processes.

Structure and Synthesis[edit]

Allopregnanolone is a metabolite of progesterone, synthesized in the body through a series of enzymatic reactions. The conversion of progesterone to allopregnanolone involves the action of the enzyme 5_-reductase, which reduces progesterone to 5_-dihydroprogesterone, followed by the action of 3_-hydroxysteroid dehydrogenase to produce allopregnanolone.

Mechanism of Action[edit]

Allopregnanolone acts primarily as a positive allosteric modulator of the GABA_A receptor, which is the major inhibitory neurotransmitter receptor in the brain. By enhancing the effects of gamma-aminobutyric acid (GABA), allopregnanolone increases inhibitory neurotransmission, leading to its sedative, anxiolytic, and anticonvulsant effects.

Physiological Roles[edit]

Allopregnanolone plays a significant role in the regulation of mood, stress response, and neuroprotection. It is involved in the modulation of anxiety, depression, and stress. During pregnancy, levels of allopregnanolone increase significantly, contributing to the regulation of mood and the prevention of seizures.

Clinical Significance[edit]

Allopregnanolone has been studied for its potential therapeutic effects in various conditions, including premenstrual dysphoric disorder (PMDD), postpartum depression, and epilepsy. It is also being investigated for its neuroprotective properties in neurodegenerative diseases such as Alzheimer's disease.

Pharmacology[edit]

As a neurosteroid, allopregnanolone can cross the blood-brain barrier and exert its effects directly on the brain. Its pharmacological profile includes sedative, anxiolytic, and anticonvulsant properties, making it a compound of interest for the development of new therapeutic agents.

Related Pages[edit]





Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.